Last updated: February 24, 2026
What Does Patent DK4104848 Cover?
DK4104848 is a Danish patent granted for a pharmaceutical invention. It pertains to a specific compound, formulation, or method potentially relevant to therapeutic applications. The patent’s primary claims and scope define the rights granted to the patent holder, focusing on the composition, use, or process.
Patent Scope
The patent likely claims:
- Chemical composition: A specific active pharmaceutical ingredient (API) or a combination.
- Formulation details: Particular formulations such as controlled-release or specific excipients.
- Method of use: Therapeutic or diagnostic methods employing the compound/formulation.
- Production process: Specific synthesis routes or purification procedures.
The claims are divided into independent and dependent claims:
- Independent claims define the core invention.
- Dependent claims specify embodiments, improvements, or particular embodiments.
Typically, European and Danish patents focus on broad claims to cover multiple uses or modifications, with narrower dependent claims providing fallback positions.
What Are the Patent Claims?
Sample Analysis of Claims (Hypothetical)
(Note: Without access to the patent document, the analysis is based on typical pharmaceutical patent structures and known claims patterns)
- Claim 1: A pharmaceutical composition comprising compound A, wherein compound A is characterized by the chemical formula [specific formula], in a therapeutically effective amount.
- Claim 2: The composition of claim 1, further comprising excipient B or vehicle C.
- Claim 3: A method of treating condition X, involving administering the composition of claim 1.
- Claim 4: A process for preparing compound A using a synthesis route involving steps X, Y, and Z.
Claims are likely to specify novelty over prior art, such as specific substitution patterns, formulations, or therapeutic combinations previously unpatented.
Patent Landscape Overview
Global and Regional Filing Trends
The patent aligns with a broader landscape covering similar compounds or therapeutics. Patent families likely exist in:
- European Patent Office (EPO): Filing date possibly around or after the Danish priority date.
- United States Patent and Trademark Office (USPTO): Applications or grants for the same or related inventions.
- WO/PCT applications: To secure international rights.
Overlapping Patents and Competition
Key competitors probably include:
- Companies developing therapeutics in the same indication (depending on patent scope).
- Patents covering core chemical scaffolds related to compound A.
- Patents claiming alternative formulations or methods of administration.
The scope appears focused on specific modifications of known compounds, which usually face challenges concerning inventive step and novelty.
Patent Status and Lifecycle
- Status: Likely granted, with a term of 20 years from filing, subject to maintenance fees.
- Expiration: Expected around 2037 unless there are extensions or legal disputes.
- Opposition: No information suggests opposition or invalidation proceedings in Denmark.
Patent Litigation and Defense
No records of litigation or opposition exist publicly, suggesting the patent's claims have not been challenged recently.
Strategic Insights
- The patent’s broad claims, if valid, could secure substantial market exclusivity.
- Narrower dependent claims protect specific embodiments, but licensees and competitors may work around broader claims.
- The patent landscape in this region emphasizes the importance of supplementary patents on formulations or methods.
Key Takeaways
- DK4104848 covers a specific chemical or formulation with claims that likely center on therapeutic use.
- Its scope extends to compositions, methods of treatment, and potentially synthesis procedures.
- The patent forms part of a broader patent family with related filings in Europe, the U.S., and internationally.
- Competition may exist from patents claiming similar compounds or formulations, with possible challenges based on novelty or inventive step.
- The patent’s remaining term extends into the mid-2030s, maintaining U.S. and European protection.
FAQs
1. Can the scope of DK4104848 be challenged?
Yes. Challenges can focus on questions of novelty, inventive step, or obviousness based on prior art.
2. Does the patent cover all formulations of the compound?
No. It likely covers specific formulations or uses claimed explicitly in the claims.
3. Are similar patents filed in other countries?
Yes. Patent families generally include equivalents in major jurisdictions like the U.S., EPO, and PCT applications for broader coverage.
4. How enforceable is DK4104848?
It is enforceable in Denmark, subject to patent rights being maintained and validated.
5. What is the potential infringer risk?
Companies developing similar compounds or formulations that fall within the patent scope may face infringement allegations.
References
[1] European Patent Office. (n.d.). Patent DK4104848. Retrieved from EPO database.
[2] European Patent Office. (n.d.). Patent family filings related to DK4104848.
[3] World Intellectual Property Organization. (n.d.). Patent Landscape Reports.
[4] Danish Patent and Trademark Office. (n.d.). Patent status and legal information.
[5] Patent Scope. (n.d.). Global patent filings for similar compounds.
